Rectal Cancer Survivorship: Impact of Low Anterior Resection Syndrome (LARS) on the Quality of Life

University Hospital, Ghent187 enrolled

Overview

Quality of life and risk factors for developing major LARS are explored. Therapeutic options were explored in the cohort experiencing major LARS

Quality of life and risk factors for developing major LARS are explored using the EORTC QLQ C30. Therapeutic options were explored in the cohort experiencing major LARS

Study Type

INTERVENTIONAL

Allocation

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

187

Conditions

Rectal Cancer Low Anterior Resection Syndrome

Interventions

LARS score/ EORTC QLQ C30BEHAVIORAL

administering questionnaire

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * low anterior resection for rectal cancer between 2006-2016 * Adults Exclusion Criteria: * abdomino perineal resection * patients who do not understand Dutch

Locations (1)

University hospital Ghent

Ghent, Oost-Vlaanderen, Belgium

Outcomes

Primary Outcomes

Assessment QoL

Assessments using questionnaire European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ C30)

Time frame: up to 10 years after rectal resection

frequencies of therapeutic options to manage LARS

Self developed questionaire to determine what therapeutic options were used to manage LARS

Time frame: up to 10 years after rectal resection

Frequency of LARS

Assessment of LARS using validated LARS Score

Time frame: up to 10 years after rectal resection

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.